Evidence map›Paper›PMID 39700304›Full record

ArticlePLoS neglected tropical diseases2024

Genetic diversity of dengue virus circulating in the Philippines (2014-2019) and comparison with dengue vaccine strains.

John Mark Velasco, Chonticha Klungthong, Piyawan Chinnawirotpisan, Paula Corazon Diones, Maria Theresa Valderama, Susie Leonardia, Wudtichai Manasatienkij, Khajohn Joonlasak, Prinyada Rodpradit, Jennifer Mateo and 5 more

Abstract readComparative Study
In one paragraph

Article in PLoS neglected tropical diseases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Tracing Dengue's Evolutionary and Phylogenetic Pathways.Current topics in microbiology and immunology · 2026
    Review
  5. Diagnostic Techniques for Dengue Virus.Current topics in microbiology and immunology · 2026
    Review
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

John Mark VelascoDepartment of Virology, WRAIR-AFRIMS, Bangkok, Thailand.ORCID 0000-0002-9397-8205
Chonticha KlungthongDepartment of Virology, WRAIR-AFRIMS, Bangkok, Thailand.
Piyawan ChinnawirotpisanDepartment of Virology, WRAIR-AFRIMS, Bangkok, Thailand.
Paula Corazon DionesDepartment of Virology, WRAIR-AFRIMS, Bangkok, Thailand.
Maria Theresa ValderamaDepartment of Virology, WRAIR-AFRIMS, Bangkok, Thailand.
Susie LeonardiaDepartment of Virology, WRAIR-AFRIMS, Bangkok, Thailand.
Wudtichai ManasatienkijDepartment of Virology, WRAIR-AFRIMS, Bangkok, Thailand.
Khajohn JoonlasakDepartment of Virology, WRAIR-AFRIMS, Bangkok, Thailand.
Prinyada RodpraditDepartment of Virology, WRAIR-AFRIMS, Bangkok, Thailand.
Jennifer MateoV Luna General Hospital, Armed Forces of the Philippines Medical Center, Quezon City, Philippines.
Vicente VilaV Luna General Hospital, Armed Forces of the Philippines Medical Center, Quezon City, Philippines.
Fatima Claire NavarroOffice of the Surgeon General, Camp General Emilio Aguinaldo, Quezon City, Philippines.
Anthony JonesDepartment of Virology, WRAIR-AFRIMS, Bangkok, Thailand.
Aaron FarmerDepartment of Virology, WRAIR-AFRIMS, Bangkok, Thailand.
Stefan FernandezDepartment of Virology, WRAIR-AFRIMS, Bangkok, Thailand.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dengue virus has four distinct serotypes and the genetic diversity within each of the four serotypes contribute to its complexity. An important aspect of dengue molecular evolutionary studies has been the dissection of the extent and structure of genetic variation among major genotypes within each serotype. It is important to understand the role of dengue genetic variability and its potential role and impact in the effectiveness of the dengue vaccine. Demographic data and blood were collected from patients seen at a tertiary hospital in the Philippines and clinically diagnosed with dengue from 2014-2019. Dengue virus (DENV) RT-PCR was used to confirm infection and positive samples underwent whole genome sequencing. Phylogenetic analysis was performed on 127 samples (25 DENV-1, 19 DENV-2, 70 DENV-3, and 13 DENV-4). We observed a serotype shift in 2014 and 2022. We detected the following genotypes per serotype for the wild-type (WT) DENV sequences: genotype IV (DENV-1), cosmopolitan (DENV-2), genotype I (DENV-3) and genotype IIa (DENV-4). WT DENV belonged to different genotypes versus the QDENGA strains and except for DENV-4, belonged to different genotypes versus the Dengvaxia strains. Comparing Dengvaxia vaccine sequences with WT DENV, we observed 23, 24, 34, and 9 positions with amino acid changes in the entire envelope protein, with 1, 5, 1, and 2 positions with amino acid changes identified among the important human monoclonal antibodies (mAbs) targeted epitope positions. We detected 24, 25, 36 and 12 positions with amino acid changes in the E protein with 0, 5, 1, and 2 positions with amino acid changes among the important mAbs targeted epitope positions for DENV-1, DENV-2, DENV-3, and DENV-4, respectively when comparing QDENGA vaccine sequences with the WT DENV. We showed low genotype complexity, genetically distinct clades and local evolution for DENV circulating in the Philippines.

Indexed as

DengueDengue VaccinesDengue VirusGenetic VariationGenotypePhylogenyAdolescentAdultAntibodies, ViralChildChild, PreschoolFemaleHumansMaleMiddle AgedPhilippinesAntibodies, ViralDengue Vaccines

Identifiers

PMID39700304
PMCPMC11698566

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.